An Illinois woman delivered her first child in 1999 by cesarean delivery and minutes thereafter experienced uterine atony with severe blood loss.
The defense claimed that the patient's uterus did not contract in spite of uterine massage, uterine compression, and administration of medications, including carboprost tromethamine, oxytocin, and methylergonovine. They argued that there was not sufficient time to perform uterine artery ligation, given the profuse life-threatening bleeding and the patient's unstable condition.
A defense verdict was returned in 2005, but a new trial was granted and resulted in a $5 million verdict. The matter ultimately was settled posttrial for $2 million.
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More
Study highlights need for interventions to prevent postpartum smoking relapse
January 21st 2025Smoking cessation during pregnancy not only reduces pregnancy complications but also lowers the risk of relapse and new smoking initiation in the first postpartum year, according to a recent study.
Read More
Timely surveillance reported in under half of HPV-positive patients
January 20th 2025A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.
Read More